We came across a bullish thesis on Tempus AI, Inc. on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on TEM. Tempus AI, Inc.'s share was trading at $64.57 as of January 28th. TEM’s trailing P/E was 41.53 according to Yahoo Finance. Morgan Stanley Lifted GE HealthCare Target to $80 in Late October, Citing Strong Orders and Backlog Wichy/Shutterstock.com Tempus AI, Inc. (NASDAQ: TEM) operates at the forefront of precision medicine, combining high-throughput genomic d ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the best Nancy Pelosi Stocks to buy in 2026. On January 27, Tempus AI, Inc. (NASDAQ:TEM) confirmed that its Immune Profile Score Test accurately predicts patient outcomes for immune checkpoint inhibitor therapy, compared with conventional biomarkers. Consequently, it continues to demonstrate superior predictive accuracy, with a hazard ratio of 0.45. Tempus AI, Inc. (TEM) Strengthens Precision Medicine with New Tools, Partnerships, and Growth Milestones Source: unspl ...

In this article, we will discuss the 10 Best Nancy Pelosi Stocks to Buy in 2026.Nancy Pelosi is one of the most closely tracked members of Congress owing to her impressive record on Wall Street. Despite announcing plans to retire from Congress, her term runs until January 2027, giving investors time to access her investment portfolio.Over the past decade, Pelosi’s portfolio has generated an estimated cumulative return of 838%, beating the S&P 500’s 256%. In 2024, her portfolio rose 70.9%, dwarfing the S&P 5 ...

Core Insights - Advancements in artificial intelligence (AI) are significantly enhancing patient care, reducing healthcare costs, and improving outcomes in the medical technology industry [1] - Generative AI is transitioning from a conceptual promise to practical applications in medical technology [1] Industry Developments - AI is expediting all phases of research and development, including generative design, virtual testing, clinical trials, and regulatory documentation [2] - The FDA is promoting the development of innovative medical devices that incorporate AI [2] Company Performance: Tempus AI (TEM) - Tempus has seen a stock increase of 27.2% over the past year, while Doximity's stock has declined by 32.8% [6] - The company is developing advanced AI algorithms and diagnostic software, collaborating with Northwestern University's Abrams Center for Alzheimer's research [7] - Tempus has received two FDA 510(k) clearances for its cardiac imaging platform and ECG-Low EF software [8] - In Q3 2025, Tempus achieved positive adjusted EBITDA of $1.5 million, with gross profit rising to $209.9 million, a 98.4% year-over-year increase [11] - EPS for 2025 is projected to be a loss of 64 cents, reflecting a 59.5% improvement from 2024 [15] Company Performance: Doximity (DOCS) - Doximity is well-positioned for AI adoption, embedding AI across its workflows and benefiting from a recent acquisition of Pathway Medical Inc. [9][13] - The company reported a 55% adjusted EBITDA margin and a 39% net income margin in fiscal 2025, with $267 million in free cash flow [14] - EPS for fiscal 2026 is projected to be $1.56, indicating a 9.9% improvement from fiscal 2025 [16] Valuation Comparison - Tempus has a forward 12-month price-to-sales (P/S) ratio of 7.24, while Doximity's is 10.38, indicating Doximity is trading at a premium [17] Conclusion - Doximity appears better positioned than Tempus, with deep AI integration, strategic acquisitions, and strong profitability metrics [18] - Tempus is recognized for its expanding AI capabilities and recent profitability milestone, indicating long-term potential in precision medicine [19]

Group 1: Ark Invest's Strategic Moves - Ark Invest acquired shares in Tempus AI Inc., Kodiak AI Inc., and WeRide Inc. on Monday [1] - The firm significantly increased its position in Tempus AI by purchasing 1,192 shares through the ARK Genomic Revolution ETF and an additional 6,545 shares via the ARK Innovation ETF, totaling approximately $523,253 [2] - Ark Invest also made a notable purchase of 47,752 shares of Kodiak AI Inc. through the ARK Autonomous Technology & Robotics ETF, valued at approximately $427,380 [4] - The firm acquired 48,260 shares of WeRide Inc. through ARKQ, resulting in a total transaction value of approximately $417,449 [5] Group 2: Notable Transactions and Market Context - Former House Speaker Nancy Pelosi's spouse exercised 50 call options on Tempus AI, adding 5,000 shares to the portfolio, valued between $50,000 and $100,000 [3] - Tempus AI's stock closed at $67.63, while Kodiak AI's stock closed at $8.95, marking a decrease of 4.58% from the previous session [2][4] - WeRide Inc. reported that its fleet has surpassed 1,000 vehicles and announced integration with Tencent's WeChat platform [5]

智通财经APP获悉，周一，美股AI应用软件股多数上扬，截至发稿，Cloudflare(NET.US)大涨超9%， Tempus AI(TEM.US)、Applovin(APP.US)涨超4%，Zoom通讯(ZM.US)涨超7%，Unity Software(U.US)涨 超3%。 ...

Core Insights - Tempus Logix Auto Transport has launched an AI-driven instant car shipping calculator aimed at enhancing transparency and certainty in vehicle transport pricing [1][3][8] Company Overview - Founded in 2018 and headquartered in California, Tempus Logix has established itself as a top-rated vehicle shipping provider by focusing on reliability, clarity, and customer trust [3][7] - The company operates as a fully licensed and bonded broker, registered with the Federal Motor Carrier Safety Administration, and maintains an A+ rating with the Better Business Bureau [7] Product Features - The new AI calculator provides real-time, accurate pricing for various vehicle types and routes, addressing common issues like fluctuating estimates and hidden fees [1][4] - Unlike traditional quoting systems, the AI calculator evaluates multiple variables simultaneously, ensuring precise pricing for customers [4] - Customers are not required to make upfront payments to secure bookings, and a money-back guarantee is offered for any processing fees until a driver is assigned [5] Service Offerings - Tempus Logix provides standard nationwide transport as well as unique services such as guaranteed pickup options and shipping to and from Hawaii [6] - The company transports a diverse range of vehicles, including motorcycles, ATVs, UTVs, RVs, boats, and heavy equipment, catering to both individual consumers and commercial clients [6] Industry Impact - The introduction of the AI-powered calculator signifies a shift towards technology-driven transparency in the vehicle transport sector, enhancing customer experience from booking to delivery [8]

Key Takeaways Tempus AI acquired Paige, expanding its proprietary dataset and establishing a digital pathology presence. Paige Predict analyzes H&E slides to predict 123 biomarkers and pathways across 16 cancer types for TEM. TEM's Paige Predict integrates results into clinical reports for faster physician insights. Investors are increasingly focused on the artificial intelligence (AI) in pathology market, which is expected to reach $1.15 billion by 2033, at a CAGR of 27.18% between 2025 and 2033 (per Grand ...

Core Insights - Tempus AI, Inc. has demonstrated resilience in the AI market, showing strong stock performance in 2025 and continuing this trend into 2026 [1] Company Performance - The company has had a strong start in 2026, indicating ongoing investor confidence despite market fears [1]

Tempus AI Trade - Ark Invest acquired a total of 13,532 shares of Tempus AI through the ARK Genomic Revolution ETF and ARK Innovation ETF, following a revenue surge of 83% year-over-year for 2025, driven by a 111% increase in diagnostics revenue [2] - The shares closed at $68.36, resulting in an investment of approximately $925,047, with an additional purchase of $5.85 million worth of shares made the previous day [3] WeRide Trade - Ark Invest purchased 166,029 shares of WeRide through the ARK Autonomous Technology & Robotics ETF, as WeRide expanded its global fleet to over 1,000 robotaxis [4] - The shares were acquired at a closing price of $9.05, totaling an investment of approximately $1.5 million [4] Roku Trade - Ark Invest sold 14,885 shares of Roku through the ARK Next Generation Internet ETF at a closing price of $107.23, amounting to approximately $1.6 million [5] - This sale occurred amid mixed analyst forecasts, with Jefferies upgrading Roku to Buy and raising its price target from $100 to $135, indicating an improved outlook for the company [5] Other Key Trades - Ark Invest sold 161,683 shares of Beam Therapeutics Inc. across ARKG and ARKK, 32,227 shares of Unity Software Inc. through ARKW, and 29,533 shares of GitLab Inc. through ARKW [7] - Additionally, the company bought 7,175 shares of Kodiak AI Inc. through ARKQ [7]